HIGH

RaySearch Laboratories Recalls RayStation Software Over Dose Calculation Error

RaySearch Laboratories recalled RayStation software on November 28, 2025, due to a serious issue with dose calculation. The software, used in radiation therapy, may not invalidate calculated doses for certain Regions of Interest. Healthcare providers and patients should stop using this software immediately.

Quick Facts at a Glance

Recall Date
November 28, 2025
Hazard Level
HIGH
Brand
RAYSEARCH LABORATORIES AB
Category
Health & Personal Care
Sold At
Unknown
At-Risk Groups
GENERAL

Hazard Information

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact RAYSEARCH LABORATORIES AB or your healthcare provider for instructions. Notification method: E-Mail

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects RayStation models 15.2.0 and 15.1.3, as well as software versions RayStation 2024A SP1 and RayStation 2024A SP2. The software is used for radiation therapy treatment planning. No price information is available.

The Hazard

The software may fail to invalidate calculated radiation doses for certain Regions of Interest that lack contours or have defined material overrides. This defect could lead to inaccurate radiation treatment.

Reported Incidents

No specific incidents or injuries have been reported related to this software issue. Health risks could arise from incorrect radiation doses.

What to Do

Stop using the RayStation software immediately. Contact RAYSEARCH LABORATORIES AB or your healthcare provider for further instructions and notifications via email.

Contact Information

For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-1108-2026 or contact RAYSEARCH LABORATORIES AB directly.

Key Facts

  • Recall date: November 28, 2025
  • Report date: January 28, 2026
  • Hazard level: High
  • No injuries reported

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeRadiation Therapy Treatment Planning System
Sold At
Unknown

Product Details

Model Numbers
UDI: 0735000201076120240508
0735000201080820241217 GTIN: 07350002010761
07350002010808 Serial Numbers: 15.1.0.852
15.2.0.107 Software Revision: RayStation 2024A SP1
RayStation 2024A SP2 Expiration Date: 2030-04-15
Report Date
January 28, 2026
Recall Status
ACTIVE

Related Recalls

HIGH

Fresenius Kabi Vancomycin Injection Recalled Over Sterility Concerns

Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Fresenius Kabi Compounding Issues Recall of Vancomycin Injection

Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Pro Numb Tattoo Numbing Spray Recalled Due to cGMP Violations

Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.

PRO NUMB SENSITIVE SKIN
cGMP deviations
Read more